A Randomised, Double-Blind, Double-Dummy, Parallel Group, Multicentre Trial to Compare the Efficacy and Safety of Four Fixed Doses of Intranasal Zolmitriptan with an Oral Dose of Zolmitriptan and Placebo in Patients with Migraine Headache.
Study identifier:311CIL/0077
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Randomised, Double-Blind, Double-Dummy, Parallel Group, Multicentre Trial to Compare the Efficacy and Safety of Four Fixed Doses of Intranasal Zolmitriptan with an Oral Dose of Zolmitriptan and Placebo in Patients with Migraine Headache.
Medical condition
migraine
Phase
N/A
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
